You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0158 Efficacy of switching from etanercept to adalimumab in rheumatoid arthritis and psoriatic arthritis patients who experienced a first-line biologic therapy failure: the fearless study

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0158 Efficacy of switching from etanercept to adalimumab in rheumatoid arthritis and psoriatic arthritis patients who experienced a first-line biologic therapy failure: the fearless study
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Favalli E, Becciolini A, Carletto A, et al
SAT0158 Efficacy of switching from etanercept to adalimumab in rheumatoid arthritis and psoriatic arthritis patients who experienced a first-line biologic therapy failure: the fearless study
Annals of the Rheumatic Diseases 2017;76:829.